Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 2468 Posts
1 2 3 ... 155
E A Value Investor In Biotech
Article By: Robert Leonard
Wednesday, April 18, 2018 9:39 AM EDT
At today's price in the current market conditions, is United Therapeutics going to outperform the market over the next 7-10 years?
In this article: UTHR
Blueprint Sinks, Loxo Rises After Trial Data On Potential Solid Tumor Treatment
Article By: The Fly
Monday, April 16, 2018 2:43 PM EDT
Shares of Blueprint Medicines are sliding after the company reported data over the weekend regarding its early-stage candidate in RET-altered tumors.
In this article: BPMC, LOXO
Merck Rises, Bristol-Myers Slides Following Cancer Meeting
Article By: The Fly
Monday, April 16, 2018 11:09 AM EDT
Shares of Merck are rising this morning, while peer Bristol-Myers is sliding, after both companies presented new data on their respective cancer immunotherapy treatments at the American Association for Cancer Research annual meeting.
In this article: BMY, MRK
Week In Review: Ping An Good Doctor Plans $1 Billion Hong Kong IPO In Mid-May
Article By: ChinaBio® Today
Saturday, April 14, 2018 4:33 PM EDT
Ping An Insurance plans to carve out its Ping An Healthcare and Technology (also known as Ping An Good Doctor APP) and IPO in Hong Kong for $1 billion at a valuation of $5 billion. The company plans to go public in the middle of May.
In this article: BGNE
Trump Overrules Sessions: Promises To Protect States' Pot Legalization Rights
Article By: Tyler Durden
Friday, April 13, 2018 3:10 PM EDT
Trump has defused the standoff and promised the top Senate Republican that he will support congressional efforts to protect states that have legalized marijuana. And Marijuana stocks are jumping.
In this article: MJ
3 Canadian LP's That Are On Sale Right Now
Article By: Technical420
Wednesday, April 11, 2018 1:40 PM EDT
Canadian cannabis stocks rallied off their lows yesterday and we are favorable on this reversal. I have highlighted three Canadian cannabis producers that we are favorable on and that investors should be watching.
In this article: APHQF, EMMBF, CRON
Alexion To Acquire Sweden's Wilson Therapeutics For $855M In Cash
Article By: The Fly
Wednesday, April 11, 2018 8:05 AM EDT
Alexion Pharmaceuticals and Wilson Therapeutics AB announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in Wilson Therapeutics by way of a tender offer.
In this article: ALXN
Acadia Pharmaceuticals Shares Plunged Yesterday After A CNN Report
Article By: TickerTV
Tuesday, April 10, 2018 11:34 AM EDT
Shares of Acadia Pharmaceuticals Inc. fell by more than 25% on Monday after an article published on the CNN website raised concerns on the company’s lead drug, Nuplazid.
In this article: ACAD
Palatin Technologies - Chart Of The Day
Article By: Jim Van Meerten
Tuesday, April 10, 2018 3:00 AM EDT
Only 2 analysts are following the stock, one rates it a strong buy and the other a buy.
In this article: PTN
Biotechs Bounce Off Bottom On Novartis Deal But Fade Later In The Day
Article By: Rod Raynovich
Monday, April 9, 2018 7:49 PM EDT
Normally this kind of M&A news would be an opportunity to load up on biotechs but technicals are still weak and crosscurrents from economic and macro news create a risk-off sentiment.
After Former Citron Short Target AveXis Gets Bought, Analyst Asks 'who's Next'
Article By: The Fly
Monday, April 9, 2018 11:25 AM EDT
AveXis shares are surging after the gene therapy researcher announced an agreement to be acquired by Novartis for $218 per share, or $8.7billion in cash. This comes two years after Citron Research made a short call of a AveXis $5 price target.
In this article: NVS, AVXS Also: BMRN, VYGR, BLUE, ONCE, RGNX
E Taking A Long View
Article By: Vivian Lewis
Monday, April 9, 2018 9:28 AM EDT
China and Trump are both making big threats as a negotiating strategy. This will go on for months and we have to examine other parts of the stock market but other market news is worthy of analysis.
Marijuana Stock Charts: How 3 Pot Plays Performed In Volatile Markets
Article By: Zacks Investment Research
Sunday, April 8, 2018 3:48 PM EDT
Trade war fears have fueled volatility in several key global markets over the past few weeks. Headlines out of Canada caused a selloff in that country’s budding marijuana market, one of the investment world’s hottest new segments.
In this article: GWPH, TWMJF, IIPR, CRON
Market Outlook For 4/8/2018
Video By: Keith Schneider
Sunday, April 8, 2018 2:35 PM EDT
Stocks are at a crossroad and we cover key support levels in US equities and what this week’s TSI (trend strength indicator) readings on US equities are telling us right now.
In this video: QQQ, IWM, SPY, GLD, AMZN, FB, IBB, XLU, XLV
Week In Review: Concord Medical Raises $240 Million For China Radiology Services
Article By: ChinaBio® Today
Saturday, April 7, 2018 4:30 PM EDT
Concord Medical Services announced that CICC Capital led an investment of between $238 million and $286 million in Concord’s subsidiary Beijing Meizhong Jiahe Hospital Management. The investors will hold 37.5% to 41.9% of Meizhong Jiahe's equity.
In this article: CCM, LLY
NewLink Genetics Plunges After Competitor IDO Drug Fails In Trial
Article By: The Fly
Friday, April 6, 2018 1:08 PM EDT
Shares of NewLink Genetics (NLNK), a clinical-stage company focused on cancer, plunged in pre-market trading after a competitor exploring the same areas of cancer treatment reported a clinical trial that did not succeed in achieving its goal.
In this article: MRK, NLNK, NKTR
1 to 16 of 2468 Posts
1 2 3 ... 155